openPR Logo
Press release

Constipation Clinical Trials 2024: FDA Approvals, Medication, Treatment Market, Therapies, MOA, ROA, Companies by DelveInsight

10-25-2024 05:34 AM CET | Health & Medicine

Press release from: DelveInsight Business Research

Constipation Clinical Trials

Constipation Clinical Trials

(Albany, USA) DelveInsight's, "Constipation Pipeline Insight 2024" report provides comprehensive insights about 15+ companies and 15+ pipeline drugs in the Constipation pipeline landscape. It covers the Constipation pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Constipation pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.

Request a sample and discover the recent advances in Constipation Treatment Drugs @ Constipation Pipeline Report- https://www.delveinsight.com/report-store/constipation-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Key Takeaways from the Constipation Pipeline Report
• July 2024- AbbVie- A Phase 2 Dose Finding Study Evaluating the Safety and Efficacy of Linaclotide in Pediatric Subjects 6 Months to Less Than 2 Years of Age With Functional Constipation (FC). Functional constipation (FC) is a common healthcare problem in children of all ages, potentially due to genetic predisposition, inadequate fiber and fluid intake, and immobility.
• April 2024:- AbbVie announced a study of Phase 2 clinical trials for Linaclotide. A Phase 2 Dose Finding Study Evaluating the Safety and Efficacy of Linaclotide in Pediatric Subjects 6 Months to Less Than 2 Years of Age With Functional Constipation (FC). There may be higher treatment burden for participants in this trial compared to their standard of care (due to study procedures). Participants will attend regular visits during the study at a hospital or clinic. The effect of the treatment will be checked by medical assessments, blood tests, checking for side effects and completing questionnaires.
• DelveInsight's Constipation pipeline report depicts a robust space with 15+ active players working to develop 15+ pipeline therapies for Constipation treatment.
• The leading companies working in the Constipation Market include Anji Pharma, Yuhan, Theravance Biopharma, RaQualia Pharma, Processa Pharmaceuticals, Abbott, AbbVie`s Inc., Albireo Pharma, Inc., AstraZeneca, Bausch Health Companies Inc., Bayer AG, Cosmo Pharma, and others.
• Promising Constipation Pipeline Therapies in the various stages of development include Linaclotide, Pradigastat Tablets 20mg, Methylnaltrexone, N-methylnaltrexone bromide (MOA-728), Prucalopride, and others.

The Constipation pipeline report provides detailed profiles of pipeline assets, a comparative analysis of clinical and non-clinical stage Constipation drugs, inactive and dormant assets, a comprehensive assessment of driving and restraining factors, and an assessment of opportunities and risks in the Constipation clinical trial landscape.

Constipation Overview
Constipation is a condition in which you may have fewer than three bowel movements a week; stools that are hard, dry, or lumpy; stools that are difficult or painful to pass; or a feeling that not all stool has passed. In many patients, constipation is associated with sluggish movement of stool through the colon.

Find out more about Constipation Treatment Landscape @ Drugs for Constipation Treatment- https://www.delveinsight.com/sample-request/constipation-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Constipation Emerging Drugs Profile
• Pradigastat : Anji Pharma
• YH 12852 : Yuhan
• RQ 00000010 : RaQualia Pharma
• RQ 00433412 : RaQualia Pharma

Constipation Pipeline Therapeutics Assessment
There are approx. 20+ key companies which are developing the therapies for Constipation. The Constipation companies which have their Constipation drug candidates in the most advanced stage, i.e. phase II include, Anji Pharma.

Learn more about the emerging Constipation Pipeline Therapies @ Constipation Clinical Trials Assessment- https://www.delveinsight.com/sample-request/constipation-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Scope of the Constipation Pipeline Report
• Coverage- Global
• Constipation Therapeutic Assessment by Product Type: Mono, Combination, Mono/Combination
• Constipation Therapeutic Assessment by Clinical Stages: Discovery, Pre-clinical, Phase I,Phase II, Phase III
• Constipation Companies- Anji Pharma, Yuhan, Theravance Biopharma, RaQualia Pharma, Processa Pharmaceuticals, Abbott, AbbVie`s Inc., Albireo Pharma, Inc., AstraZeneca, Bausch Health Companies Inc., Bayer AG, Cosmo Pharma, and others.
• Constipation Pipeline Therapies- Linaclotide, Pradigastat Tablets 20mg, Methylnaltrexone, N-methylnaltrexone bromide (MOA-728), Prucalopride, and others.

Dive deep into rich insights for new drugs for Constipation Treatment, Visit @ Constipation Market Drivers and Barriers, and Future Perspective- https://www.delveinsight.com/sample-request/constipation-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Table of Content
1. Introduction
2. Executive Summary
3. Constipation: Overview
4. Pipeline Therapeutics
5. Therapeutic Assessment
6. Constipation- DelveInsight's Analytical Perspective
7. Late Stage Products (Phase III)
8. Drug name : Company name
9. Drug profiles in the detailed report…..
10. Mid Stage Products (Phase II)
11. Pradigastat : Anji Pharma
12. Drug profiles in the detailed report…..
13. Early Stage Products (Phase I)
14. RQ 00000010: RaQualia Pharma
15. Drug profiles in the detailed report…..
16. Preclinical and Discovery Stage Products
17. RQ 00433412 : RaQualia Pharma
18. Drug profiles in the detailed report…..
19. Inactive Products
20. Constipation Key Companies
21. Constipation Key Products
22. Constipation - Unmet Needs
23. Constipation - Market Drivers and Barriers
24. Constipation - Future Perspectives and Conclusion
25. Constipation Analyst Views
26. Constipation Key Companies
27. Appendix

Trending Reports:
• Thyroid Eye Disease Market: https://www.delveinsight.com/report-store/thyroid-eye-disease-market
• Trigeminal Neuralgia Market Size: https://www.delveinsight.com/report-store/trigeminal-neuralgia-market
• Ventricular Hypertrophy Market: https://www.delveinsight.com/report-store/hypertrophic-cardiomyopathy-market
• Vertigo Market: https://www.delveinsight.com/report-store/vertigo-market
• Abetalipoproteinemia Market: https://www.delveinsight.com/report-store/abetalipoproteinemia-market
• Achondroplasia Market: https://www.delveinsight.com/report-store/achondroplasia-market
• Acute Lung Injury Market: https://www.delveinsight.com/report-store/acute-lung-injury-market
• Acute Ocular Pain And Inflammation Market: https://www.delveinsight.com/report-store/acute-ocular-pain-market
• Acute Ocular Pain Market: https://www.delveinsight.com/report-store/acute-ocular-pain-aop-market
• Acute On Liver Failure Market: https://www.delveinsight.com/infographics/acute-on-chronic-liver-failure-aclf-market
• Age-related Macular Degeneration Market: https://www.delveinsight.com/report-store/age-related-macular-degeneration-amd-market
• Airway Stent Market Market: https://www.delveinsight.com/report-store/airway-stent-market
• Alagille Syndrome Market: https://www.delveinsight.com/report-store/alagille-syndrome-market
• Allergic Rhinitis Market: https://www.delveinsight.com/report-store/allergic-rhinitis-market
• Alpha-mannosidosis Market: https://www.delveinsight.com/report-store/alpha-mannosidosis-market
• Androgenetic Alopecia Market: https://www.delveinsight.com/report-store/androgenetic-alopecia-market
• Angioedema Market: https://www.delveinsight.com/report-store/hereditary-angioedema-market
• Anorectal Malformation Market: https://www.delveinsight.com/report-store/anorectal-malformation-market
• Anterior Cruciate Ligament Injuries Market: https://www.delveinsight.com/report-store/anterior-cruciate-ligament-injuries-market
• Antibody Mediated Rejection Market: https://www.delveinsight.com/report-store/antibody-mediated-rejection-market
• Antibody-mediated Rejection Market: https://www.delveinsight.com/report-store/antibody-mediated-rejection-market
• Aortic Stenosis Market: https://www.delveinsight.com/report-store/aortic-stenosis-market
• Artificial Lung Devices Market: https://www.delveinsight.com/report-store/artificial-lung-devices-pipeline-insight-and-competitive-landscape
• Atypical Teratoid Rhabdoid Tumors Market: https://www.delveinsight.com/report-store/atypical-teratoid-rhabdoid-tumors-market
• Becker Muscular Dystrophy Market: https://www.delveinsight.com/report-store/becker-muscular-dystrophy-market
• Bone Densitometers Market: https://www.delveinsight.com/report-store/bone-densitometers-market

Contact Us:
Ankit Nigam
Manager Marketing
info@delveinsight.com
+14699457679
https://www.delveinsight.com/consulting/conference-coverage-services

About DelveInsight
DelveInsight is a leading Life Science market research and business consulting company recognized for its off-the-shelf syndicated market research reports and customized solutions to firms in the healthcare sector.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Constipation Clinical Trials 2024: FDA Approvals, Medication, Treatment Market, Therapies, MOA, ROA, Companies by DelveInsight here

News-ID: 3709326 • Views:

More Releases from DelveInsight Business Research

Chronic Gout Pipeline 2025: Latest FDA Approvals, Clinical Trials, and Emerging Therapies Assessment by DelveInsight
Chronic Gout Pipeline 2025: Latest FDA Approvals, Clinical Trials, and Emerging …
Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, Chronic Gout pipeline constitutes key companies continuously working towards developing Chronic Gout treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. "Chronic Gout Pipeline Insight, 2025" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Chronic Gout Market. The Chronic Gout Pipeline
Diverticulitis Market Anticipated to Expand Rapidly During 2023-2032, Says DelveInsight
Diverticulitis Market Anticipated to Expand Rapidly During 2023-2032, Says Delve …
DelveInsight's "Diverticulitis Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Diverticulitis, historical and forecasted epidemiology as well as the Diverticulitis market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan. To Know in detail about the Diverticulitis market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Diverticulitis Market Forecast https://www.delveinsight.com/sample-request/diverticulitis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr Some of the key facts of the Diverticulitis
Traumatic Brain Injury Market Expected to Experience Major Growth by 2034, According to DelveInsight
Traumatic Brain Injury Market Expected to Experience Major Growth by 2034, Accor …
DelveInsight's "Traumatic Brain Injury Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Traumatic Brain Injury, historical and forecasted epidemiology as well as the Traumatic Brain Injury market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan. The latest healthcare forecast report provides an in-depth analysis of Traumatic Brain Injury, offering comprehensive insights into the Traumatic Brain Injury revenue trends,
Acquired Immunodeficiency Syndrome Market Set to Grow Substantially Through 2032, DelveInsight Projects
Acquired Immunodeficiency Syndrome Market Set to Grow Substantially Through 2032 …
DelveInsight's "Acquired Immunodeficiency Syndrome Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Acquired Immunodeficiency Syndrome, historical and forecasted epidemiology as well as the Acquired Immunodeficiency Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. To Know in detail about the Acquired Immunodeficiency Syndrome market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Acquired Immunodeficiency Syndrome Market

All 5 Releases


More Releases for Constipation

Evolving Market Trends In The Opioid-Induced Constipation Treatment Industry: St …
The Opioid-Induced Constipation Treatment Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Expected Opioid-Induced Constipation Treatment Market Size During the Forecast Period? The opioid-induced constipation treatment market, valued at $1.78 billion in 2024, is projected to increase to $1.9 billion in 2025, growing
Key Trends Shaping the Future Constipation Laxative Market From 2025-2034: Innov …
How Are the key drivers contributing to the expansion of the constipation laxative market? The rising prevalence of constipation is expected to boost the growth of the constipation laxative market. Constipation, characterized by infrequent or difficult bowel movements, is becoming more common due to changes in diet, sedentary lifestyles, inadequate fluid intake, and medical conditions. Constipation laxatives help relieve this condition by stimulating bowel movements or softening stools. A 2024 survey
Leading Element Driving Change in the Constipation Laxative Market in 2025: Incr …
What Is the Estimated Market Size and Growth Rate for the Constipation Laxative Market? The market for constipation laxatives has seen substantial expansion in the past few years. It is projected to further expand from $7 billion in 2024 to $7.44 billion in 2025, with a compound annual growth rate (CAGR) of 6.4%. Factors contributing to this growth during the historical period include an increase in the elderly population, sedentary lifestyles,
[Latest] Constipation Treatment Market : An Overview
The ""Constipation Treatment Market"" is expected to reach USD xx.x billion by 2031, indicating a compound annual growth rate (CAGR) of xx.x percent from 2024 to 2031. The market was valued at USD xx.x billion In 2023. Growing Demand and Growth Potential in the Global Constipation Treatment Market, 2024-2031 Verified Market Research's most recent report, ""Constipation Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2030,"" provides an in-depth
How to Improve Constipation - Cassia Fistula Extract
Cassia Fistula Extract is a natural plant ingredient extracted from the friut of the Cassia Fistula tree and is widely used in traditional Chinese medicine and modern medicine. Here are some common applications of Cassia Fistula Extract [https://www.ie-extract.com/cassia-fistula-extract-cassia-fistula-extract-treatment-of-constipation-product/]: Promotes bowel movement and relieves constipation: Cassia Fistula Extract is believed to promote bowel movement and relieve constipation. Research shows that its active ingredients can stimulate intestinal motility, increase bowel movement frequency, and improve
Opioid Induced Constipation Treatment Market
Opioids are medications that work on opioid receptors in order to generate morphine-like effects. These are mainly used therapeutically to relieve pain and are often abused by individuals addicted to them. Opioids comprises opiates, a conventional name that points to drugs that are derivatives of opium, including morphine. Constipation means bowel actions that are sporadic or hard to go by. The fecal matter is often dry and hard. Some of